Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oregovomab (2 trials)
Carcinoma, Ovarian Epithelial (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (1 total)